Search / Trial NCT06616545

French Observatory for Patients with Type 3 Glycogenosis

Launched by INSTITUT DE MYOLOGIE, FRANCE · Sep 26, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

ClinConnect Summary

The French Observatory for Patients with Type 3 Glycogenosis is a clinical trial aimed at understanding Glycogen Storage Disease Type III (GSD-III), a condition that affects how the body stores and uses glycogen, a type of sugar. This disease can lead to problems like low blood sugar and muscle weakness, especially as people get older. The trial involves creating an online registry where information about patients with GSD-III will be collected. This will help researchers learn more about the disease's natural progression, how it affects patients, and what factors might influence the outcomes.

To participate in this study, patients must have a confirmed diagnosis of GSD-III based on specific genetic tests. The trial is open to people of all ages and genders who are willing to share their health information. By joining, participants will contribute valuable data that can lead to a better understanding of GSD-III, even though there is currently no specific treatment besides managing diet to help control symptoms. This study is an important step toward improving care and support for those living with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with molecularly characterised Glycogen Storage Disease Type III
  • Exclusion Criteria:
  • Patients diagnosed with GSD type 3 refusing to take part in the study

About Institut De Myologie, France

The Institut de Myologie, based in France, is a leading research center dedicated to the study of muscle diseases and disorders. Renowned for its multidisciplinary approach, the institute combines cutting-edge scientific research with clinical expertise to advance understanding and treatment of myopathies. With a strong emphasis on innovation, the Institut de Myologie actively sponsors clinical trials aimed at developing new therapeutic strategies and improving patient outcomes. Its collaborative environment fosters partnerships with academic institutions, healthcare providers, and industry stakeholders, positioning it at the forefront of myology research and clinical trials in Europe.

Locations

Clamart, , France

Le Kremlin Bicêtre, , France

Paris, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0